Milvus Hits 35,000 GitHub Stars as AI Developers Embrace Open-Source Vector Database
Most Popular Vector Database on GitHub Powers Thousands of AI Applications Worldwide REDWOOD CITY, Calif., May 30, 2025 /PRNewswire/ -- Zilliz, creator of the leading open-source vector database Milvus, today announced that Milvus has achieved...
China's HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC
SHANGHAI, May 29, 2025 /PRNewswire/ -- The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan, China's first domestically developed antibody-drug conjugate (ADC), for treatment of adult patients with...
LONGi selected on the 2025 FORTUNE China ESG Impact List
XIAN, China, May 28, 2025 /PRNewswire/ -- On May 16, the FORTUNE China officially unveiled its ESG Impact list, with LONGi securing its place on the ranking once again for its outstanding practices in environmental, social, and governance (ESG)...
SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types
SAN DIEGO, May 26, 2025 /PRNewswire/ -- A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare®, a novel, non-invasive multi-omics blood test designed for the early detection...
ExploMar Unveils the SUPER/ISLAND Battery Platform to empower 200km range electric water transportation
VENICE, Italy, May 26, 2025 /PRNewswire/ -- As a technology company focused on high-performance electric outboard motor systems, ExploMar has already launched the WAVE 300, WAVE 150+, and WAVE 70+ electric outboard motor systems, along with the 5S...
Global Times: Ningbo-Zhoushan Port's global connectivity seen from a small button controlling bridge crane
BEIJING, May 26, 2025 /PRNewswire/ -- When Zhu Shijie started working at the Chuanshan port area of Ningbo-Zhoushan Port in East China's Zhejiang Province in 1999 as a bridge crane operator loading and unloading containers onto or from ships, the...
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant...
BioDlink Clinches Brazil GMP Audit to Strengthen Emerging Markets Growth
International recognition of quality system with GMP-compliance in the key markets of Brazil, Indonesia, Egypt, Colombia and Argentina Passed its first-ever on-site PIC/S audit, reinforcing its strong commitment to stringent international regulatory...
Game-Changing Partnership: JETOUR x PUBG MOBILE Redefine Youth Lifestyle Trends in Middle East
ABU DHABI, UAE, May 19, 2025 /PRNewswire/ -- Drawing on deep insights into digital-era consumption trends, JETOUR, a leading brand in "Travel+" auto market has partnered with PUBG MOBILE, a global powerhouse in mobile gaming, as the official auto...
Visionary: Pioneering a New Era in Cancer Screening
TORONTO, May 16, 2025 /PRNewswire/ -- Recently, Visionary has achieved a significant breakthrough in the field of early cancer screening and home self - testing technologies, attracting widespread attention from the industry. American Precision...